Wegovy 0.5 mg (Semaglutide) Injection

Description

Progress to the next stage of your weight loss journey with the Wegovy 0.5 mg Pen, designed for Weeks 5 to 8 of the semaglutide titration schedule. This dose builds upon your body’s initial adjustment to GLP-1 therapy and begins more actively supporting appetite suppression and weight management. It’s an essential step in your transition toward the clinically effective maintenance doses of Wegovy.

💊 Key Features of Wegovy 0.5 mg

• Step-up dose in the Wegovy treatment plan

• Improves weight loss while minimizing side effects

• Once-weekly subcutaneous injection

• Works with diet and exercise for effective results

• Regulates appetite and blood sugar

📦 What’s Included

• 1 pre-filled pen delivering 0.5 mg of semaglutide

• Instructions for storage and use

• Injection safety cap and plunger

🌟 Benefits of the 0.5 mg Step

• Enhances the body’s response to semaglutide after completing 0.25 mg

• Helps establish more noticeable weight loss results

• Maintains digestive comfort during titration

• Ideal for continued hunger regulation without overwhelming side effects

• Prepares the body for 1.0 mg and higher therapeutic doses

🩺 How to Use

• Inject once every 7 days—same day each week

• Administer subcutaneously in the abdomen, thigh, or upper arm

• Rotate injection sites weekly

• Do not exceed the prescribed dose or alter schedule without guidance

⚠️ Safety Information / Warnings

• Approved for chronic weight management in adults with obesity (BMI ≥30) or overweight (BMI ≥27 with related health risks)

• Do not use if you or a family member have a history of medullary thyroid cancer or multiple endocrine neoplasia syndrome type 2

• Common side effects: nausea, vomiting, constipation, diarrhea, fatigue, abdominal pain

• Use caution if on insulin or sulfonylureas—may increase hypoglycemia risk

• Consult your healthcare provider before use if pregnant, breastfeeding, or planning pregnancy

❄️ Storage & Handling

• Store pens unopened in the refrigerator: 2°C to 8°C (36°F to 46°F)

• Once in use, pens may be stored at room temperature (up to 30°C / 86°F) for up to 28 days

• Do not freeze. Discard if exposed to freezing temperatures

• Keep pens out of direct sunlight and store in the original carton when not in use

❓ Frequently Asked Questions

Q: Why do I need to move from 0.25 mg to 0.5 mg?
A: 0.25 mg is a starter dose to help your body adapt. 0.5 mg begins the therapeutic phase and is critical to continued weight loss progress.

Q: Will I feel more side effects at 0.5 mg?
A: Most users tolerate 0.5 mg well since the body has already adjusted. However, mild nausea or fatigue may occur in some people during this step.

Q: Can I stay on 0.5 mg long-term?
A: Wegovy is designed to gradually increase the dose. While 0.5 mg may offer some benefits, the full therapeutic effect is usually reached at 1.0 mg or higher.

Q: What if I miss my weekly dose?
A: If it’s within 5 days of your missed dose, take it as soon as possible. If more than 5 days have passed, skip the missed dose and resume your schedule. Never double up.

Q: How Wegovy helps with weight loss
A: Wegovy (semaglutide) helps with weight loss by mimicking a hormone called GLP-1, which regulates appetite and blood sugar levels. By mimicking this hormone, Wegovy reduces appetite, slows stomach emptying, and promotes feelings of fullness, leading to decreased calorie intake and, consequently, weight loss.

Q: Who is the manufacturer of Wegovy?
A: Novo Nordisk makes the drug semaglutide, used to treat diabetes under the brand names Ozempic and Rybelsus and obesity under the brand name Wegovy.